This study aimed to investigate the therapeutic effect of curcumin in lipopolysaccharide (LPS) induced neonatal acute lung injury (ALI) and the possibly associated molecular mechanisms.
Background
Acute lung injury (ALI) is one of the devastating situation needing intensive care, and is life threatening [1] . Pathologically, ALI is characterized by the impaired integrity, increased permeability and activated inflammation of alveolar epithelium, which leads to the pulmonary edema, hypoxemia, atelectasis, and hyaline membrane [2] . Neonates are extremely susceptible to ALI which is one of the most frequent causes of mortality in newborns [3] . Lipopolysaccharide (LPS) is known as the bacterial bio-active component involved in many pathological conditions by activating inflammatory cascade. It is implicated that LPS takes the responsibility as the inducer of ALI and thus has been used in establishing ALI animal models in literature [4] .
The role of LPS in inducing ALI is depending on its pro-inflammatory activities. LPS could recruit monocytes infiltration and aggregation, promote inflammatory cytokines synthesis and secretion and induce alveolar epithelial apoptosis [5] . Peroxisome proliferator-activated receptor g (PPARg) is the member of nuclear hormone receptor family and one of the isoforms of PPARs. PPARg activation exerted anti-inflammatory and anti-apoptotic effects in many inflammatory diseases models including ALI [6] . High-mobility group box 1 (HMGB1) is synthesized and secreted by activated immunocytes, such as monocytes and macrophages, and has been considered as one of the important inflammatory inducers. After binding with receptor for advanced glycation end products (RAGE), HMGB1 activates the nuclear factor kB signaling [7] . Thus, the expression levels pro-inflammatory cytokines including tumor necrosis factor a (TNFa), interleukin 6 (IL6), and transforming growth factor b1 (TGFb1) are upregulated [8] [9] [10] . Notably, according to several previous studies, HMGB1/RAGE was considered as one of the downstream targets of PPARg through modulating the mediator heme oxygenase 1 (HO1) [11] .
As a natural polyphenol, curcumin is one of the bio-active extracts of the Chinese medicinal plant Curcuma longa linn which is also known as turmeric. Curcumin possesses a wide spectrum of biological activities such as antioxidant, antiproliferative, and anti-inflammatory effects [12] . Several previous investigations pointed out that curcumin acted partially as an agonist of PPARg [13] . Moreover, administration of curcumin attenuated lung injuries in paraquot-, LPS-, and Staphylococcus aureus-induced ALI animal models [14] [15] [16] . However, very few studies have investigated the protective role of curcumin in ALI neonatal animal models. The involvement of PPARg signaling has also been rarely studied. In the present study, the protective role of curcumin on an established LSP-induced ALI model in neonatal rats was studied. Furthermore, the molecular mechanism concerning PPARg signaling was investigated. We believe that results from this study could not only suggest to us more information about the mechanism of neonatal ALI, but also provide the theoretical groundwork for potential application of curcumin on neonatal ALI. Intraperitoneal injections of LPS (3 mg/kg bodyweight, SigmaAldrich) were administrated to rats to induce ALI. Rats also received intraperitoneal injections of curcumin (Sigma-Aldrich) at various concentrations (1.5, 3.0, and 6.0 mg/kg bodyweight daily for 7 consecutive days) after LPS exposure. The PPARg inhibitor bisphenol A diglycidyl ether (BADGE) (Sigma-Aldrich) at 30 mg/kg bodyweight daily for 7 consecutive days after LPS exposure.
Material and Methods

Lung edema evaluation
In this study, lung edema was evaluated by both PaO 2 and lung wet/dry weight ratio (W/D). Isoflurane inhalation was used to anesthetize the animals. Blood samples were harvested from abdominal aorta. PaO 2 was measured by an automatic blood gas analyzer (Bobas B123, Roche). Right lungs were weighted to get measurements of wet weight (W). The right lung was dried at 70°C for 48 hours then the dry weight (D) was measured. The W/D was then calculated.
Bronchoalveolar lavage fluid (BALF) harvest and ELISA
Bronchoalveolar lavage fluid (BALF) was acquired by lavaging the lung with sterile PBS by intratracheal injection 3 times. Supernatant of BALF was separated by centrifugation at 800 g at 4°C for 10 minutes. ELISA kits were used to detect the concentrations of HMGB1 (Shino-Test Corporation), secretory RAGE (R&D), TNFa (R&D), TGFb1 (R&D), and IL6 (R&D) in BALF. The protocols of ELSIA were carried out per manufacturers' instructions.
Western blotting
Lung tissue was homogenized with ice-cold RIPA lysis buffer system (Santa Cruz) supplemented with PMSF (Santa Cruz). The supernatant was collected after the lysates were centrifuged at 1 4000 g at 4°C for 20 minutes. The cytoplasmic protein was extracted by Cytoplasmic Protein Extraction kit (Beyotime) and the nuclear protein was acquired by using Nuclear Protein Extraction kit (Beyotime). Proteins were then subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then electronically transferred to polyvinylidene fluoride ( (1: 2500, Sigma-Aldrich), and GAPDH (1: 4000, Sigma-Aldrich). Horseradish peroxidase (HRP)-conjugated secondary antibodies (1: 4000, Abcam; 1: 4000, Sigma-Aldrich) were used to incubate the membranes, which were then developed by SuperSignal West Pico Chemiluminescent Reagent (Pierce). The immunoblots were visualized on x-ray films.
PPARg binding activity
The DNA-binding activity of PPARg was evaluated by electrophoretic mobility shift assay (EMSA) in the current study. The oligonucleotide (sequence: 5'-CAAATCAGGTCAAAGGTCA-3') for peroxisome proliferator response element was synthesized by TaKaRa. The oligonucleotide was then labeled by g32P-ATP by using a T4 Polynucleotide Kinase kit (Promega). EMSA/Gel-shift binding buffer (Beyotime) was used to accomplish the binding between nuclear protein and the oligonucleotide. Then the protein-oligonucleotide complex was subjected to EMSA/Gel-shift running buffer (Beyotime) and separated from free probes by electrophoresis with a 5% native polyacrylamide gel. The resulted gel was then transferred to 3MM filter paper (GE Health Care) and dried. The probes were visualized on x-ray films after exposure for 20 hours at -80°C
Statistics
Data acquired in this study was presented as (mean ±SD) and were analyzed by using software SPSS (version 16.0, SPSS). Student's t-tests and one-way ANOVA were performed to analyze the differences between groups. NSK tests were carried out as post-hoc tests. P<0.05 was considered statistically significant.
Results
Curcumin alleviated pulmonary edema in neonatal rats with ALI
The results are shown in Figure 1 
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inhibitory effects on inflammatory factors in BALF from neonatal rats with ALI.
Curcumin administration increased PPARg activity in lungs from neonatal rats with ALI EMSA was used to evaluate the PPARg activity and the results are shown in Figure 3 . In lungs from neonatal rats with ALI, the PPARg activity decreased significantly. The curcumin administration increased the PPARg activity in lungs of neonatal rats with ALI in a concentration-dependent manner. However, the PPARg activity inhibitor BADGE prevented curcumin in increasing the activity of PPARg in lungs of neonatal rats with ALI.
Curcumin inhibited HMGB1/RAGE-induced inflammation by activating PPARg/HO1 signaling in lungs from neonatal rats with ALI in Figure 4A . The expression levels of HMGB1 ( Figure 4B , white columns), RAGE ( Figure 4B , deep blue columns), TNFa ( Figure 4C , blue columns), IL6 ( Figure 4C , white columns) and TGFb1 ( Figure 4C , deep blue columns) increased while the expression level of HO1 ( Figure 4B , blue columns) was downregulated in lungs of neonatal rats with ALI. The administration of curcumin dramatically decreased the expression levels of HMGB1, RAGE, TNFa, TGFb1, and IL6 and upregulated expression level of HO1 in lungs of neonatal rats in a concentrationdependent manner. However, co-administration of BADGE impaired curcumin's effects on decreasing expression levels of RAGE, TNFa, TGFb1, and IL6 and on increasing expression level of HO1 in lungs from neonatal rats with ALI.
Discussion
Resulted from severe bacterial infection, ALI is taking responsibility for mortality in newborns that are more vulnerable than adults [17, 18] . The onset of ALI is considered as one of the early manifests of multiple organ failure which is correlated with endotoxin or LPS in circulation [18] . It has been established that inflammation plays a critical role in initiation and maintenance of ALI [19] . The inflammation cytokines take responsibility of increasing permeability of pulmonary epithelium, inducing lung tissue damage and accumulation of neutrophils which characterize ALI and lead to lung edema. Elevation of TNFa level was correlated with ALI in septic pediatric critically ill patients and animal models [20, 21] . IL6 is identified as one of the biomarkers in monitoring ALI [22] . Changes of TGFb1 would affect the synthesis and deposition of collagens which was especially important for developing lungs [23] . Monitoring the changes of TGFb1 was important for assessments of therapeutic outcomes and prognosis of neonatal ALI [24] . In this study, we found that the indicators of lung edema changed significantly in neonatal rats with ALI: PaO 2 decreased while the W/D increased dramatically. Moreover, the concentrations of inflammatory cytokines, namely HMGB1, RAGE, TNFa, IL6, and TGFb elevated significantly in both BALF and lung tissue of neonatal rats with ALI.
Biological extracts from Chinese medicinal herbs have been attracting attention from both investigators and doctors due to the various pharmacological effects on many pathological conditions. Curcumin is one of the typical polyphenol extracted the roots of Curcuma longa linn. Modern pharmacological investigations have revealed the anti-inflammatory effects of curcumin in many inflammation-associated diseases [25] . Several recent investigations indicated the protective and therapeutic effects of curcumin in animal models of multiple organ distress syndrome (MODS) [26] . In this study, we administrated curcumin to neonatal rats with ALI. As a result, the PaO 2 decrease and W/D elevation were dramatically attenuated, indicating that lung edema was relieved by curcumin. We also found that in BALF and lung tissue the levels of the inflammatory cytokines HMGB1, RAGE, IL6, and TGFb were suppressed by curcumin administration.
It was evidenced that the activation of PPARg played a role as an inflammatory suppressor by interacting with several signaling pathways [27] . For instance, HO1 is one of the downstream effectors of PPARg which conducts the anti-inflammatory signal of PPARg [28] . It was suggested that the activation of PPARg/HO1 lead to inhibition of the inflammatory HMGB1/RAGE axis, which facilitates the transcriptional initiation of IL6, TNFa, and TGFb1 [29] . In the current study, our results showed that the activation of PPARg/HO1 was significantly suppressed in neonatal rats with ALI, which was evidenced by decreased PPARg LAB/IN VITRO RESEARCH activity and HO1 expression level. As a result, the HMGB1/RAGE signaling was activated, leading to inflammation. Previous studies have indicated the involvement of curcumin in activating PPARg [30] . In this study, we found that curcumin administration dramatically increased PPARg activity in lungs harvested from neonatal rats with ALI. As a result, the expression level of HO1 was elevated, indicating the activation of PPARg/HO1 signaling. Thus, the signaling transduction of pro-inflammatory HMGB1/RAGE pathway was blocked and the generation of IL6, TNFa, and TGFb were downregulated by curcumin.
We investigated whether the specific PPARg inhibitor BADGE was used to treat neonatal rats with ALI as a co-administration of curcumin. BADGE is a synthetic PPARg inhibitor, acting as a ligand for PPARg which was been reported to antagonize the ability of ligands such as rosiglitazone [31] . Our study results showed that BADGE impaired the curcumin-induced activation of the PPARg/HO1 pathway. Thus, the inhibition of HMGB1/RAGE activation was absolved in neonatal rats with ALI that received co-administration of curcumin and BADGE. These results further suggested that PPARg/HO1 was the molecular target for curcumin in neonatal ALI.
Conclusions
Our study demonstrated the potent therapeutic effects of curcumin in a neonatal ALI animal model. This effect was conducted by curcumin's ability to activate the PPARg/HO1 pathway which further inhibited the pro-inflammatory HMGB1/RAGE pathway. Results in this study provided evidence for activation of PPARg as a new strategy of neonatal ALI treatment. Additionally, the potential value of the application of curcumin and curcumin-related compounds in neonatal ALI treatment could be foreseen.
